MEDTRONIC PUERTO RICO OPERATIONS CO. ACTIVA; Stimulator, electrical, implanted, for essential tremor
|
Back to Search Results |
|
Model Number 37603 |
Device Problems
Impedance Problem (2950); Adverse Event Without Identified Device or Use Problem (2993); Insufficient Information (3190); Patient Device Interaction Problem (4001)
|
Patient Problem
Insufficient Information (4580)
|
Event Date 07/01/2021 |
Event Type
Injury
|
Manufacturer Narrative
|
Concomitant medical products: product id: 3708660, serial# unknown.Product type extension.Product id: 3389s-40.Product type lead section.Other relevant device(s) are: product id: 3708660, serial/lot #: unknown.Product id: 3389s-40, serial/lot #: unknown.If information is provided in the future, a supplemental report will be issued.
|
|
Event Description
|
It was reported that a lead revision is needed for patient.The extension and neurostimulator were removed and they were leaving a defective lead implanted so they can perform mri imaging to replace lead at another time.Patient started coming to office due to intermittent therapy issues around july of last year.Every time patient was checked at the office, everything appeared to be good/okay.Today, the 0 electrode is defective and they would like to use it for programming.
|
|
Manufacturer Narrative
|
Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
|
Event Description
|
The manufacturer's representative (rep) reported it couldn't be determined what component was the root cause of the impedance issue.
|
|
Manufacturer Narrative
|
Section d information references the main component of the system.Other relevant device(s) are: product id 3708660 lot# serial# (b)(6) product type extension product id 3389s-40 lot# va1ndya product type lead.Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
|
Event Description
|
Additional information received from the manufacturer¿s representative (rep) reported it was determined an explant and reimplant would be best for new therapy coverage.There was believed to be an issue with the connection between the original lead/extension due to positional changes.Upon further examination during the procedure, no visual problem could be found to confirm a ¿broken wire.¿ new leads were implanted due to disease progression.After the stage 2 procedure on (b)(6) 2022, and initial programming shortly thereafter, the problem was resolved and the patient had better therapy with no side effect as previously noted.
|
|
Search Alerts/Recalls
|
|
|